Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent　― A Randomized Comparison Through 5 Years in Japan ―

Ken Kozuma(Teikyo University Hospital), Takayuki Okamura(Yamaguchi University), Hajime Kusano, Yuji Hamazaki, Jiro Ando(University of Tokyo Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Divine Ediebah(Abbott (Canada)), Takeshi Kimura(Municipal Hirakata City Hospital), Yuji Ikari(Tokai University), Kengo Tanabe

Circulation Journal

March 25, 2020

10.1253/circj.cj-19-1184

Cited by 24

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

|JAMA|2019|848

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

|The Lancet|2018|781

JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome

|Circulation Journal|2019|582

Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents

|New England Journal of Medicine|1996|507

JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease

|Circulation Journal|2020|363